Suppr超能文献

抗精神病药恶性综合征与氯氮平

Neuroleptic malignant syndrome and clozapine.

作者信息

Reddig S, Minnema A M, Tandon R

机构信息

University of Michigan Medical Center, Ann Arbor 48109-0120.

出版信息

Ann Clin Psychiatry. 1993 Mar;5(1):25-7. doi: 10.3109/10401239309148920.

Abstract

Clozapine is an atypical neuroleptic drug that was initially thought not to cause neuroleptic malignant syndrome (NMS). We report a case of NMS associated with clozapine as a single agent that developed in a patient with no prior history of NMS. In contrast to other reported cases of NMS with clozapine monotherapy in which rigidity was reported to be absent, our patient had classic NMS with lead-pipe rigidity. NMS should be included in the differential diagnosis of a febrile patient with a history of any neuroleptic treatment, including clozapine.

摘要

氯氮平是一种非典型抗精神病药物,最初被认为不会引起抗精神病药物恶性综合征(NMS)。我们报告一例与氯氮平单药治疗相关的NMS病例,该病例发生在一名既往无NMS病史的患者身上。与其他报道的氯氮平单药治疗导致NMS的病例不同,那些病例中未报告有强直,而我们的患者出现了伴有铅管样强直的典型NMS。对于有任何抗精神病药物治疗史(包括氯氮平)的发热患者,鉴别诊断时应考虑NMS。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验